Randomized, double-blind, placebo-controlled trial of acetaminophen for preventing mood and memory effects of prednisone bursts

被引:12
作者
Brown, E. Sherwood [1 ]
Denniston, Daren [1 ]
Gabrielson, Barry [1 ]
Khan, David A. [2 ]
Khanani, Sadia [1 ]
Desai, Shuchi [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Psychoneuroendocrine Res Program, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Allergy & Immunol, Dallas, TX 75390 USA
关键词
Acetaminophen; cognition; corticosteroid; depression; hippocampus; mania; memory; prednisone; prevention; DECLARATIVE MEMORY; RATING-SCALE; STRESS; PERFORMANCE; OUTPATIENTS; CORTICOSTEROIDS; HIPPOCAMPUS; DEPRESSION; COGNITION; NEURONS;
D O I
10.2500/aap.2010.31.3338
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Corticosteroids are commonly associated with changes in mood, memory, and the hippocampus. Declarative memory decline occurs rapidly after corticosteroid administration. Minimal research has focused on interventions to prevent or reverse corticosteroid effects on the human brain and associated adverse psychiatric effects. Acetaminophen has neuro protective properties in animal models. We examined acetaminophen add-on therapy in patients prescribed corticosteroids. Thirty outpatients prescribed oral high-dose prednisone therapy for asthma (n = 28) or allergic rhinitis (n = 2) were randomized to similar to 7 days of acetaminophen (4000 mg/day) or placebo in a double-blind fashion at the same time as prednisone. Mood was assessed with the Hamilton Rating Scale for Depression, Young Mania Rating Scale, and Activation subscale of the Internal State Scale. Memory was assessed with the Rey Auditory Learning Test and asthma symptoms with the Asthma Control Questionnaire. Between-group differences were assessed using mixed ANCOVAs and within-group changes were examined with paired t-tests. Baseline mean depression scores were elevated. In the total sample, depressive and asthma symptoms improved significantly, while declarative memory worsened during prednisone therapy. No between treatment-group differences were found in mood or memory measures. Change in asthma symptoms with receiving prednisone was not related to change in mood or memory. Prednisone therapy was associated with a reduction in depressive symptom severity and decline in declarative memory that was not related to changes in asthma symptoms. This is consistent with prior research suggesting that prednisone impairs memory and may have antidepressant properties. Acetaminophen did not attenuate corticosteroid-induced mood or memory changes. (Allergy Asthma Proc 31:331-336, 2010; doi: 10.2500/aap.2010.31.3338)
引用
收藏
页码:331 / 336
页数:6
相关论文
共 50 条
  • [41] Transcranial photobiomodulation increases cognition and serum BDNF levels in adults over 50 years: A randomized, double-blind, placebo-controlled trial
    de Oliveira, Bruna H.
    Lins, Elisa F.
    Kunde, Naiara F.
    Salgado, Afonso S. I.
    Martins, Leidiane M.
    Bobinski, Franciane
    Vieira, Willians F.
    Cassano, Paolo
    Quialheiro, Anna
    Martins, Daniel F.
    [J]. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2024, 260
  • [42] PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2): Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial
    de Ridder, Inger R.
    den Hertog, Heleen M.
    van Gemert, H. Maarten A.
    Schreuder, A. H. C. M. L.
    Ruitenberg, Annemieke
    Maasland, E.
    Saxena, Ritu
    van Tuijl, Jordie H.
    Jansen, Ben P. W.
    Van den Berg-Vos, Renske M.
    Vermeij, Frederique
    Koudstaal, Peter J.
    Kappelle, L. Jaap
    Algra, Ale
    van der Worp, H. Bart
    Dippel, Diederik W. J.
    [J]. STROKE, 2017, 48 (04) : 977 - 982
  • [43] A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline in Patients with Alcohol Use Disorder
    Brown, E. Sherwood
    Van Enkevort, Erin
    Kulikova, Alexandra
    Escalante, Chastity
    Nakamura, Alyson
    Ivleva, Elena I.
    Holmes, Traci
    [J]. ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 43 (02): : 317 - 323
  • [44] Estrogen for Alzheimer's disease in women - Randomized, double-blind, placebo-controlled trial
    Henderson, VW
    Paganini-Hill, A
    Miller, BL
    Elble, RJ
    Reyes, PF
    Shoupe, D
    McCleary, CA
    Klein, RA
    Hake, AM
    Farlow, MR
    [J]. NEUROLOGY, 2000, 54 (02) : 295 - 301
  • [45] Celecoxib adjunctive therapy for acute bipolarmania: a randomized, double-blind, placebo-controlled trial
    Arabzadeh, Somayeh
    Ameli, Niusha
    Zeinoddini, Atefeh
    Rezaei, Farzin
    Farokhnia, Mehdi
    Mohammadinejad, Payam
    Ghaleiha, Ali
    Akhondzadeh, Shahin
    [J]. BIPOLAR DISORDERS, 2015, 17 (06) : 606 - 614
  • [46] Flexible Dosed Duloxetine in the Treatment of Fibromyalgia: A Randomized, Double-blind, Placebo-controlled Trial
    Arnold, Lesley M.
    Clauw, Daniel
    Wang, Fujun
    Ahl, Jonna
    Gaynor, Paula J.
    Wohlreich, Madelane M.
    [J]. JOURNAL OF RHEUMATOLOGY, 2010, 37 (12) : 2578 - 2586
  • [47] Psychological Treatment of Comorbid Insomnia and Depression: A Double-Blind Randomized Placebo-Controlled Trial
    Blom, Kerstin
    Forsell, Erik
    Hellberg, Monica
    Svanborg, Cecilia
    Jernelov, Susanna
    Kaldo, Viktor
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2024, 93 (02) : 100 - 113
  • [48] A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI)
    Ferris, Steven
    Schneider, Lon
    Farmer, Mildred
    Kay, Gary
    Crook, Thomas
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2007, 22 (05) : 448 - 455
  • [49] MIDAS (Modafinil in Debilitating Fatigue After Stroke) A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial
    Bivard, Andrew
    Lillicrap, Thomas
    Krishnamurthy, Venkatesh
    Holliday, Elizabeth
    Attia, John
    Pagram, Heather
    Nilsson, Michael
    Parsons, Mark
    Levi, Christopher R.
    [J]. STROKE, 2017, 48 (05) : 1293 - 1298
  • [50] OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females
    Brin, Mitchell F.
    Durgam, Suresh
    Lum, Arlene
    James, Lynn
    Liu, Jeen
    Thase, Michael E.
    Szegedi, Armin
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2020, 35 (01) : 19 - 28